Buy, Sell, Hold: stocks and sectors are being tracked by analysts today

Just Dial

Brokerage: Morgan Stanley | Rating: Underweight | Target: Rs 360

The global research firm said that Q2 revenue didn’t show signs of pick up while margin beat was cost-led. Further, he highlighted that the firm reported first half revenue growth of 7.8 percent year on year against FY18 estimate of 10.7 percent. A stronger-than-expected traction in search plus business is a key upside risk.

Gujarat Gas

Brokerage: Morgan Stanley | Rating: Overweight | Target: Rs 1,143

The global research firm said that the conviction On the firm’s ability to deliver 50% earnings growth over FY17-20 remains high. It expects growth underlying core demand to remain strong and margin could recover as LNG price volatility settles.

Westlife Dvpt

Brokerage: Axis Cap | Rating: Upgrade to Buy | Target: Rs 300

Axis Cap sees the firm to benefit from its continued focus on innovation and better customer experience. It sees 17% sales growth over fy17-22e on high-single digit same-store-sales growth. The firm also increased gross margin estimate on better product mix, menu innovation.

Brokerage: CLSA | Rating: Buy | Target: Raised to Rs 320

CLSA pointed out that same-store-sale growth sustains momentum at >8% YoY. Further, higher footfalls & internal measures helping the franchise to deliver ahead-of-industry growth and added that the management is confident of sustaining current growth momentum. The brokerage upgraded operating profit estimate by 10-14 percent.

KEC Intl

Brokerage: Emkay | Rating: Upgrade to buy | Target: Raised to Rs 390

The brokerage said that the company had steady performance despite GST transition concerns. It upgraded FY18/19 EPS estimates by 5.8%/9.7% respectively. Going forward, it expects revenue to increase by 17% CAGR over fy17-19 and profit could spike by 35 percent CAGR over FY17-19.

Brokerage: Quant | Rating: Buy | Target: Raised to Rs 405

The broking firm said that operating performance of the firm was healthy, while volatile raw material prices and currency fluctuation were key risks to estimates.

Indian Bank

Brokerage: PhillipCap | Rating: Buy | Target: Raised to Rs 450

The brokerage expects 38%/24% earnings growth for FY18/FY19. Further, it said that the bank is sufficiently capitalised to fund its near-term growth. Going forward, it expects FPO worth Rs 1,500-1,700 crore to pare government stake to 75% from 82.1%.

Capital Ways Financial Services
605, Industry House , AB road Indore (MP) 452001
7771800797, 8517810864


 Free Trial

0 comments:

Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar, Prakash Gaba for short term

Mitessh Thakkar of mitesshthakkar.com suggests selling Aurobindo Pharma with a stop loss of Rs 731 for target of Rs 696 and Bank of Baroda...